Nano cancer therapy strategies

Area of Science:

• Oncology
• Nanotechnology
• Biomedical Engineering

Background:

• Cancer remains a leading cause of death globally, with millions diagnosed annually.
• Cancer cells often overexpress specific surface proteins compared to healthy cells.
• Current cancer treatments face challenges, necessitating novel therapeutic strategies.

Purpose of the Study:

• To review nanoparticle technology platforms for cancer therapy.
• To explore the impact of these platforms on preclinical and clinical cancer treatment.
• To highlight advancements in multifunctional nanoparticles for enhanced efficacy.

Main Methods:

• Conjugating gold nanoparticles to antibodies for targeted cancer cell binding.
• Developing nanoparticle delivery systems for cancer treatment.
• Reviewing existing preclinical and clinical nanoparticle technologies.

Main Results:

• Nanoparticle-antibody conjugates demonstrate potential for specific cancer cell targeting.
• Nanoparticle drug delivery systems offer unique approaches to cancer therapy.
• Advanced nanoparticles incorporate multifunctionality and targeting for improved outcomes.

Conclusions:

• Nanoparticle technology platforms show significant promise in advancing cancer therapy.
• Targeted nanoparticle delivery can enhance treatment efficacy against challenging cancers.
• Further development of preclinical and clinical nanoparticle applications is crucial for future cancer treatment strategies.